DOD FY12 Duchenne Muscular Dystrophy Therapeutic Idea Award

 

The vision of the FY12 Duchenne Muscular Dystrophy Research Program (DMDRP) is to extend and improve the function, quality of life, and lifespan for all individuals diagnosed with DMD. As such, the DMDRP is seeking to fund research to accelerate the development and clinical testing of new therapeutics and increase our understanding of successes and failures in clinical trials. The DMDRP Therapeutic Idea Award mechanism is designed to promote new ideas that are still in the early stages of development with the potential to yield high-impact data and new avenues of investigation for novel therapeutics for DMD treatment. This award mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in DMD therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity.

General information about this opportunity
Last Known Status
Deleted 12/07/2012 (Archived.)
Program Number
W81XWH-12-DMDRP-TIA
Federal Agency/Office
Agency: Department of Defense
Office: U.S. Army Medical Research Acquisition Activity
Type(s) of Assistance Offered
Cooperative Agreement, Grant
Number of Awards Available
1
What is the process for applying and being award this assistance?
Deadlines
11/07/2012
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?
Headquarters Office
PA HELP and eReceipt HELP: 301-682-5507; help@cdmrp.org
E-mail Address
help@cdmrp.org
Financial Information
Obligations
$480,000.00

 


Related Federal Grants


Federal Grants Resources